Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancer.

Ziehr DR, Chen MH, Zhang D, Braccioforte MH, Moran BJ, Mahal BA, Hyatt AS, Basaria SS, Beard CJ, Beckman JA, Choueiri TK, D'Amico AV, Hoffman KE, Hu JC, Martin NE, Sweeney CJ, Trinh QD, Nguyen PL
BJU Int. 2015 116 (3): 358-65

PMID: 25124891 · DOI:10.1111/bju.12905

MeSH Terms (13)

Aged Aged, 80 and over Androgen Antagonists Antineoplastic Agents, Hormonal Coronary Disease Goserelin Humans Leuprolide Male Middle Aged Prostatic Neoplasms Retrospective Studies Risk Factors

Connections (1)

This publication is referenced by other Labnodes entities:

Links